SK bioscience Co., the biopharmaceutical arm of South Korea's SK Group, said Wednesday it has achieved a "final victory" in a ...

In the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) was a top performer, from both a share-price and an ...

Novavax’s closely watched COVID-19 vaccine is on track for full approval after additional discussions with the Food and Drug ...

On Tuesday, the U.S. Department of Health and Human Services announced that the government will invest $176 million in ...

The regulator was at odds with the new HHS secretary's stance on vaccines. Moderna's vaccine development pipeline could be affected. The vaccine maker's shares tumbled following the resignation of ...

A view of the headquarters of vaccine maker Moderna on May 08, 2020 in Cambridge, Massachusetts. - Image: Maddie Meyer / Staff (Getty Images) Moderna and other vaccine maker stocks plummeted ...

CAMBRIDGE, MA / ACCESS Newswire / March 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Australian Therapeutic Goods Administration (TGA) has granted approval for mRESVIA® (mRNA ...

At the congress, Moderna will share findings from three oral presentations and nine poster presentations, including an e-poster. The research covers the immunogenicity and safety of its mRNA vaccines ...

SK bioscience, the biopharmaceutical arm of South Korea's SK Group, said on Wednesday it has achieved a "final victory" in a ...